{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:21:08Z","timestamp":1780957268594,"version":"3.54.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Catheter-related bladder discomfort (CRBD) is a frequent occurrence following urinary catheterization during surgical procedures, as well as a commonly experienced bladder pain syndrome after surgery. There have been various studies on drugs and interventions to manage CRBD, but their comparative efficacy and safety are still a topic of debate. We conducted a meta-analysis to assess the efficacy and safety of nefopam for managing postoperative CRBD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A systematic search of PubMed, Embase, Cochrane Library, and Web of Science was conducted to find randomized controlled trials (RCTs) on using nefopam in postoperative CRBD. The study employed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Data analysis was performed using RevMan version 5.4.1.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Five RCTs with 405 patients were analyzed to evaluate the efficacy of nefopam on postoperative CRBD. Short-term and long-term periods were defined as within 6\u00a0h and longer than 12\u00a0h after surgery, respectively. The incidence and severity of CRBD were compared between the two groups during these time periods. The analysis proved that nefopam reduced the short-term incidence of postoperative CRBD (RR 0.36; 95% CI, 0.18\u20130.70; <jats:italic>p<\/jats:italic> = 0.003, I<jats:sup>2<\/jats:sup> = 78%) and the long-term incidence (RR 0.49; 95% CI, 0.32\u20130.74; <jats:italic>p<\/jats:italic> = 0.0007, I<jats:sup>2<\/jats:sup> = 0%) significantly. We compared the incidence of moderate-to-severe CRBD between groups based on the scaling system (none, mild, moderate, and severe). This was used to assess the severity of postoperative CRBD. The results showed that patients in the nefopam group had a significantly lower incidence of moderate-to-severe CRBD compared to those in the placebo group in the short-term (RR 0.19; 95% CI, 0.10\u20130.34; <jats:italic>p<\/jats:italic> &amp;lt; 0.00001; I<jats:sup>2<\/jats:sup> = 0%). However, there were no significant differences between the two groups in the incidence of moderate-to-severe CRBD in the long-term (RR 0.61; 95% CI, 0.21\u20131.76; <jats:italic>p<\/jats:italic> = 0.36; I<jats:sup>2<\/jats:sup> = 0%). There were no significant variations in the occurrence of adverse events between the nefopam and control groups, mainly including postoperative nausea and vomiting (PONV) (RR 1.14; 95% CI, 0.40\u20133.21; <jats:italic>p<\/jats:italic> = 0.81), and tachycardia (RR 0.25; 95% CI, 0.03\u20132.11, <jats:italic>p<\/jats:italic> = 0.20).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The findings of this meta-analysis indicate that nefopam significantly reduced the incidence of short or long-term postoperative CRBD. Nefopam decreased the severity of postoperative CRBD, particularly significantly reducing the occurrence of moderate to severe CRBD in the short-term. Overall, patients have good tolerance and no apparent side effects.<\/jats:p><jats:p><jats:bold>Systematic Review Registration<\/jats:bold>: identifier PROSPERO (<jats:ext-link>CRD42023475012<\/jats:ext-link>)<\/jats:p>","DOI":"10.3389\/fphar.2023.1305844","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T10:20:20Z","timestamp":1700821220000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The systematic review and meta-analysis evaluated the efficacy and safety of nefopam for catheter-related bladder discomfort based on randomized controlled trials"],"prefix":"10.3389","volume":"14","author":[{"given":"Junpeng","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyuan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jopan.2019.06.013","article-title":"Incidence and severity of catheter-related bladder discomfort among nonurological adult patients in a postanesthesia care unit","volume":"35","author":"Bach","year":"2020","journal-title":"J. Perianesth Nurs."},{"key":"B3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1089\/end.2014.0670","article-title":"Management of catheter-related bladder discomfort in patients who underwent elective surgery","volume":"29","author":"Bai","year":"2015","journal-title":"J. Endourol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/bja\/aeq375","article-title":"Analgesic efficacy and haemodynamic effects of nefopam in critically ill patients","volume":"106","author":"Chanques","year":"2011","journal-title":"Br. J. Anaesth."},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00540-022-03130-y","article-title":"Single-dose intravenous nefopam on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of prostate: a randomized, double-blind placebo-controlled trial","volume":"37","author":"Charoenpol","year":"2023","journal-title":"J. Anesth."},{"key":"B6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4097\/kja.d.18.27113","article-title":"Effects of nefopam on catheter-related bladder discomfort in patients undergoing ureteroscopic litholapaxy","volume":"71","author":"Cheon","year":"2018","journal-title":"Korean J. Anesthesiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/s1734-1140(11)70580-1","article-title":"Nefopam enhances the protective activity of antiepileptics against maximal electroshock-induced convulsions in mice","volume":"63","author":"Czuczwar","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0755-4982(04)98555-7","article-title":"The management of acute pain in ambulatory patients. The place of nefopam","volume":"33","author":"Dacero","year":"2004","journal-title":"Presse Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"CD012509","DOI":"10.1002\/14651858.CD012509.pub2","article-title":"Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews","volume":"10","author":"Els","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/bja\/aen267","article-title":"Nefopam for the prevention of postoperative pain: quantitative systematic review","volume":"101","author":"Evans","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"B11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/0028-3908(93)90064-a","article-title":"Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice","volume":"32","author":"Fuller","year":"1993","journal-title":"Neuropharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"32S-9S","DOI":"10.1097\/PRS.0000000000000680","article-title":"Perioperative opioid usage: avoiding adverse effects","volume":"134","author":"Funk","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.21608\/ejhm.2022.266027","article-title":"Prophylactic tramadol versus nefopam for post-operative catheter-related bladder discomfort in patients undergoing elective percutaneous nephrolithotomy: randomized controlled trial","volume":"89","author":"Gad","year":"2022","journal-title":"Egypt. J. Hosp. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/00003495-198019040-00001","article-title":"Nefopam: a review of its pharmacological properties and therapeutic efficacy","volume":"19","author":"Heel","year":"1980","journal-title":"Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/jcm8040519","article-title":"Effects of intraoperative nefopam on catheter-related bladder discomfort in patients undergoing robotic nephrectomy: a randomized double-blind study","volume":"8","author":"In","year":"2019","journal-title":"J. Clin. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5213\/inj.2040108.054","article-title":"Catheter-related bladder discomfort: how can we manage it?","volume":"24","author":"Jang","year":"2020","journal-title":"Int. Neurourol. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/apha.12824","article-title":"Urothelium update: how the bladder mucosa measures bladder filling","volume":"220","author":"Janssen","year":"2017","journal-title":"Acta Physiol. (Oxf)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11596-014-1315-z","article-title":"Predictors of catheter-related bladder discomfort after urological surgery","volume":"34","author":"Li","year":"2014","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00228-021-03251-5","article-title":"Different interventions for preventing postoperative catheter-related bladder discomfort: a systematic review and meta-analysis","volume":"78","author":"Li","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6002059","DOI":"10.1155\/2021\/6002059","article-title":"Comparison between tramadol and butorphanol for treating postoperative catheter-related bladder discomfort: a randomized controlled trial","volume":"2021","author":"Lin","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"816995","DOI":"10.3389\/fphar.2022.816995","article-title":"Meta-analysis of the efficacy and safety of ketamine on postoperative catheter-related bladder discomfort","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/21681805.2018.1524929","article-title":"The effect of preoperative nefopam treatment on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumor resection: a randomized double-blind study","volume":"52","author":"Park","year":"2018","journal-title":"Scand. J. Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12894-023-01195-9","article-title":"Comparative effectiveness of interventions for managing urological postoperative catheter-related bladder discomfort: a systematic review and network meta-analysis","volume":"23","author":"Ren","year":"2023","journal-title":"BMC Urol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/luts.12322","article-title":"Pooled analysis of the efficacy and safety of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort","volume":"13","author":"Shi","year":"2021","journal-title":"Low. Urin Tract. Symptoms"},{"key":"B26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/cpt1975185part1530","article-title":"Nefopam and morphine in man","volume":"18","author":"Sunshine","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/bja\/83.3.501","article-title":"Fatal nefopam overdose","volume":"83","author":"Urwin","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"B29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.12968\/bjon.2008.17.4.28712","article-title":"Causes and management of indwelling urinary catheter-related pain","volume":"17","author":"Wilson","year":"2008","journal-title":"Br. J. Nurs."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/01.ju.0000031061.70559.40","article-title":"Current and future pharmacological treatment for overactive bladder","volume":"168","author":"Yoshimura","year":"2002","journal-title":"J. Urol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13741-021-00217-0","article-title":"The efficacy and safety of antimuscarinics for the prevention or treatment of catheter-related bladder discomfort: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Zhou","year":"2021","journal-title":"Perioper. Med. (Lond)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1305844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T10:20:24Z","timestamp":1700821224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1305844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":31,"alternative-id":["10.3389\/fphar.2023.1305844"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1305844","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"article-number":"1305844"}}